# Topical Ruxolitinib Lichen Planus

> **NCT03697460** · PHASE2 · COMPLETED · sponsor: **Aaron R. Mangold** · enrollment: 12 (actual)

## Conditions studied

- Lichen Planus

## Interventions

- **DRUG:** INCB018424

## Key facts

- **NCT ID:** NCT03697460
- **Lead sponsor:** Aaron R. Mangold
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2020-06-25
- **Final completion:** 2020-08-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03697460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03697460, "Topical Ruxolitinib Lichen Planus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03697460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*